[Antilipidemic agents].
D000328:Adult; D000438:Alcohols / Q000008:administration & dosage / Q000009:adverse effects; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001645:Biguanides / Q000627:therapeutic use; D001796:Blood Protein Disorders / Q000188:drug therapy; D001835:Body Weight; D002792:Cholestyramine Resin / Q000008:administration & dosage / Q000009:adverse effects; D002994:Clofibrate / Q000008:administration & dosage; D004035:Diet Therapy; D006801:Humans; D006940:Hyperemia / Q000139:chemically induced; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000628:therapy; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000009:adverse effects; D013974:Thyroxine / Q000009:adverse effects
D000438:Alcohols; D000924:Anticholesteremic Agents; D001645:Biguanides; D008055:Lipids; D008074:Lipoproteins; D009539:Nicotinic Acids; D002792:Cholestyramine Resin; D002994:Clofibrate; D013974:Thyroxine
Antilipidämische Substanzen.